Rolando Cimaz

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier et al. · New England Journal of Medicine · 2012 · 709 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Jurgen Sota, Antonella Insalaco, Rolando Cimaz et al. · Frontiers in Pharmacology · 2019 · 616 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

Gillian Rice, Yoandris del Toro Duany, Emma M. Jenkinson et al. · Nature Genetics · 2014 · 591 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Pierre Quartier, Florence Allantaz, Rolando Cimaz et al. · Annals of the Rheumatic Diseases · 2010 · 549 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Anti-inflammatory and immunosuppressive drugs and reproduction.

Monika Østensen, Munther A. Khamashta, Michael D. Lockshin et al. · Arthritis Research & Therapy · 2006 · 534 citations · Full text

Medicine, Maternal Health, Pharmacology +17